Bristol-Myers, AstraZeneca Expand Diabetes Alliance

Bristol-Myers Squibb Company and AstraZeneca have announced the completion of the acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb.
Pharmaceutical Business Review